Sooma depression treatment receives HSA approval in Singapore
12.12.2017
Helsinki, Finland – December 12, 2017
Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA) approval for its leading therapeutic platform Sooma tDCS. This approval allows Sooma and its distributor Equip Medical Pte Ltd to immediately market its products in Singapore.
Sooma Depression Treatment is a safe and effective treatment for major depressive disorder (MDD) delivered with an easy-to-use portable device. The therapy works by delivering a mild electrical current through electrodes placed on the head and relieving the symptoms of MDD.
Latest news
Sooma closes 2025 with major milestones in improved access to better depression and pain care globally
Read more
FDA approved tDCS for at-home depression treatment
Read more
Science round-up webinar: tDCS in Depression and Chronic Pain – Clinical Advancements 2025
Read more